-
x
x
bid
ask
03:51 AM
Bearish
10
Bullish
32
sentiment
day range
52 week range
Prev Close
Open
Low
High
Volume0.00
Avg. Volume0.00
Market Cap0.00
Inst. Own
Beta
Short Ratio
Div & Yield /
EPS
P/E
1yr Target
50day MA
200day MA
^DJI
Dow Jones Industrial Average
33963.80
05:35 PM
-
106.60
0.31%
^IXIC
NASDAQ Composite
13211.80
05:15 PM
-
12.20
0.09%
^GSPC
S&P 500
4320.06
05:35 PM
-
9.94
0.23%
AAPL
174.95
+0.16 (0.09%)
Apple Inc.
174.79
9 @ 04:00 PM
9 x 174.93
9 x 175.10
+
0.86
0.49%
GOOG
131.44
+0.19 (0.15%)
Alphabet Inc.
131.25
9 @ 04:00 PM
8 x 131.50
9 x 131.63
-
0.11
0.08%
AMZN
129.30
+0.18 (0.14%)
Amazon.com, Inc.
129.12
9 @ 04:00 PM
8 x 129.27
10 x 129.28
-
0.21
0.16%
MSFT
316.81
-0.20 (0.06%)
Microsoft Corporation
317.01
11 @ 04:00 PM
8 x 316.81
13 x 317.01
-
2.52
0.79%
BABA
88.50
+0.20 (0.23%)
Alibaba Group Holding Limited
88.30
8 @ 04:01 PM
8 x 88.50
8 x 88.58
+
4.19
4.98%
NFLX
379.65
-0.16 (0.04%)
Netflix, Inc.
379.81
10 @ 04:00 PM
9 x 379.82
11 x 380.43
-
4.34
1.13%
TSLA
244.16
-0.72 (0.29%)
Tesla, Inc.
244.88
11 @ 04:00 PM
9 x 243.86
13 x 244.16
-
10.82
4.23%
NVDA
415.74
-0.36 (0.09%)
NVIDIA Corporation
416.10
21 @ 04:00 PM
11 x 415.58
31 x 415.90
+
5.93
1.45%
AMD
96.08
-0.12 (0.12%)
Advanced Micro Devices, Inc.
96.20
13 @ 04:00 PM
14 x 96.01
12 x 96.13
+
0.09
0.09%
MU
68.89
+0.01 (0.01%)
Micron Technology, Inc.
68.88
14 @ 04:00 PM
14 x 68.85
13 x 68.95
+
0.98
1.44%
SPY
430.69
+0.27 (0.06%)
SPDR S&P 500 ETF Trust
430.42
31 @ 04:00 PM
31 x 430.52
30 x 430.80
-
0.97
0.22%
TQQQ
35.68
+0.05 (0.15%)
ProShares UltraPro QQQ
35.63
35 @ 04:00 PM
40 x 35.68
29 x 35.73
+
0.02
0.07%
BRK-A
544000.00
-2215.00 (0.41%)
Berkshire Hathaway Inc.
546215.00
10 @ 04:00 PM
9 x 544500.00
10 x 547042.00
-
4815.00
0.87%
| Day Gain | ||
| Gain | ||
| Market Val | ||
| Costs | ||
| Cash | ||
| Portfolio | ||
| Realized | ||
| Dividend |
News
...
| What Do Penny Stocks Offer Over Blue Chips? | pennystocks.com • |
| The Most Important Penny Stocks Trading Indicators | pennystocks.com • |
| Penny Stocks Trading: How News Plays a Role | pennystocks.com • |
| Why Is ObsEva (OBSV) Stock Up 93% Today? | investorplace.com • |
| Why Is ObsEva (OBSV) Stock Up 61% Today? | investorplace.com • |
| Why ObsEva (OBSV) Stock Is Down 36% Today | investorplace.com • |
Profile
...
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.
Earning
...
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2023-03-23 | 2022-12 | 0 | N/A | N/A | N/A |
| 2022-12-01 | 2022-09 | -0.14 | N/A | N/A | N/A |
| 2022-08-17 | 2022-06 | -0.22 | N/A | N/A | N/A |
| 2022-05-17 | 2022-03 | -0.25 | N/A | N/A | N/A |
| 2022-03-10 | 2021-12 | -0.22 | N/A | N/A | N/A |
| 2021-11-04 | 2021-09 | -0.22 | N/A | N/A | N/A |
Upgrade / Downgrade
...
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2022-08-30 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| 2022-06-03 | Cantor Fitzgerald | Upgrade | Overweight | |
| 2022-04-26 | Canaccord Genuity | Upgrade | Buy | |
| 2022-03-28 | Aegis Capital | Upgrade | Buy | |
| 2022-03-28 | HC Wainwright & Co. | Upgrade | Buy | |
| 2021-11-29 | HC Wainwright & Co. | Upgrade | Buy |
Insider Holder
...
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-02-27 | LOUMAYE ERNEST | Director | 6.00M | Purchase |
Institution Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2022-12-30 | Sofinnova Investments, Inc. | 4.75M | 483.51K | 4.37% |
| 2022-12-30 | NEA Management Company, LLC | 4.59M | 466.91K | 4.22% |
| 2022-12-30 | Credit Suisse Ag/ | 1.75M | 178.21K | 1.61% |
| 2022-12-30 | Zurcher Kantonalbank (Zurich Cantonalbank) | 668.49K | 68.05K | 0.62% |
| 2022-12-30 | Pictet Asset Management SA | 363.77K | 37.03K | 0.33% |
| 2022-12-30 | Cutter & Co. Brokerage, Inc. | 201.20K | 20.48K | 0.19% |
Fund Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2022-11-29 | Fidelity NASDAQ Composite Index Fund | 82.23K | 8.37K | 0.08% |
This topic has been deleted. Only users with topic management privileges can see it.
-
Alert a buy at 3.71 and if anyone is interested in learning dm me hari25sabari@gmail.com
-
Need to break 4.19
-
-
-
ObSeva Announces Positive Pilot Study Results From Linzagolix In Adenomyosis
Obseva SA (NASDAQ: OBSV) announced the publication in the journal Fertility and Sterility of a case report from a pilot study assessing the use of linzagolix for the treatment of uterine adenomyosis. The study showed the patient treated with linzagolix saw alleviation of symptoms such as cessation of bleeding, improvement in pelvic pain, resolution of anemia and shrinkage of uterus at week 12.
The symptoms continued to improve with the subsequent 12 weeks of treatment, and the effect lingered at eight weeks following the treatment.
Pending confirmation of the results in additional patients, ObsEva said it may pursue additional studies to support supplemental labeling for the treatment of adenomyosis in reproductive-age women.
-
ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis
GENEVA, Switzerland and BOSTON, MA (June 4, 2020) – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today reported publication in the journal Fertility and Sterility of “Gonadotropin-releasing Hormone Antagonist (linzagolix): a New Therapy for Uterine Adenomyosis,” a case report from a pilot study assessing the use of linzagolix for the treatment of uterine adenomyosis.
-
-
-
-
-
Huge buys now. Stock barely went up
-
Don’t believe the bots telling you to hold. This things is manipulated and going down hard. Won’t be back for months of at all. Unless they decide to pump
-
Sucked all the gains out of my account
-
I’m out with a loss. Had to stop the bleeding
-
@John smith. Where did you read offering?
-
Stuck here at 4.55 till this turns around
if it goes all the way to 52 week low I’ll add more and hold. Hopefully good news in March -
Why so much after hours activity. More movements than open hrs. Anyone?
-
Market is booming today while this dog sleeps
-
What Do Penny Stocks Offer Over Blue Chips?
pennystocks.com • -
The Most Important Penny Stocks Trading Indicators
pennystocks.com • -
Penny Stocks Trading: How News Plays a Role
pennystocks.com • -
Why Is ObsEva (OBSV) Stock Up 93% Today?
investorplace.com • -
Why Is ObsEva (OBSV) Stock Up 61% Today?
investorplace.com • -
Why ObsEva (OBSV) Stock Is Down 36% Today
investorplace.com • -
Hot Penny Stocks For Your Buy List in September? 3 to Watch
pennystocks.com • -
Why Is ObsEva (OBSV) Stock Down 70% Today?
investorplace.com • -
ObsEva: Ignored, But Long-Term Prospects Exist On Recent Progress
seekingalpha.com • -
7 Penny Stocks With 10x Potential This Year
investorplace.com • -
ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference
globenewswire.com • -
What Are the Top 7 Penny Stocks? And Should You Buy?
investorplace.com • -
5 Hot Penny Stocks To Watch With Premarket Momentum & News
pennystocks.com • -
Trading Penny Stocks? Top Stock Market News for February 1st, 2022
pennystocks.com • -
Obseva (OBSV) Stock: Why The Price Surged Up Today
pulse2.com • -
7 Penny Stocks to Buy for January
investorplace.com • -
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
globenewswire.com • -
7 of the Best Penny Stocks Under $3 for 2022 to Buy Now
investorplace.com • -
Why Are ObsEva Shares Trading Higher Today?
benzinga.com • -
4 Biotech Penny Stocks to Watch With New Catalysts
pennystocks.com • -
Obseva (OBSV) Stock: Why The Price Jumped Today
pulse2.com • -
7 Penny Stocks to Book Profits on Before 2022
investorplace.com • -
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
globenewswire.com • -
7 Hot Penny Stocks to Buy in Q4 for 10-Bagger Potential
investorplace.com • -
ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer
globenewswire.com • -
5 Penny Stocks To Watch For September With Upcoming Events
pennystocks.com • -
7 Hottest Penny Stocks to Pick Up Now
investorplace.com • -
ObsEva Announces Second Quarter 2021 Financial Results and Business Update
globenewswire.com • -
ObsEva to Present at Upcoming Investor Conferences
globenewswire.com • -
7 Penny Stocks For Your Watch List This Week If You Like Biotech In July
pennystocks.com • -
ObsEva Announces Oral Presentation at the RCOG Virtual World Congress 2021
globenewswire.com • -
ObsEva Announces Proposed Changes to the Composition of its Board of Directors
globenewswire.com • -
ObsEva Announces First Quarter 2021 Financial Results and Business Update
globenewswire.com • -
ObsEva appoints Clive Bertram as Chief Commercial Officer
globenewswire.com • -
ObsEva Annual General Meeting 2021
globenewswire.com • -
ObsEva Announces Year End 2020 Financial Results and Business Update
globenewswire.com • -
ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference
globenewswire.com • -
ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference
globenewswire.com • -
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
globenewswire.com • -
ObsEva Provides Business Outlook for 2021
globenewswire.com • -
7 Penny Stocks That Actually Have Buy Ratings
investorplace.com • -
7 Penny Stock Bubbles That Are About to Burst
investorplace.com • -
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
globenewswire.com • -
OBSV Stock Price Increased 61.51%: Why It Happened
pulse2.com • -
7 Stocks to Buy With That Second Stimulus Check As More Plan to Save It
investorplace.com • -
ObsEva Provides Update on Yselty® (Linzagolix) Clinical Development Program
globenewswire.com • -
ObsEva appoints David Renas as Chief Financial Officer
globenewswire.com • -
ObsEva appoints Brian O'Callaghan as Chief Executive Officer
globenewswire.com • -
ObsEva Announces Second Quarter 2020 Financial Results and Business Update
finance.yahoo.com • -
ObsEva SA to present at ESHRE Virtual 36th Annual Meeting, July 5-8, 2020
finance.yahoo.com • -
Is ObsEva SA (OBSV) A Good Stock To Buy?
finance.yahoo.com • -
ObsEva Annual General Meeting 2020
finance.yahoo.com • -
These 3 Biotech Stocks Have Massive Upside Potential, Says Wedbush
finance.yahoo.com • -
ObsEva Announces First Quarter 2020 Financial Results and Business Update
finance.yahoo.com • -
Goldman Sachs Group Inc. Sells 48,929 Shares of Obseva SA (NASDAQ:OBSV)
thelincolnianonline.com •
